Announcements Trials

Browse Landscape

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Venous Thromboembolism 18 Neoplasms 11 Venous Thrombosis 9 Pulmonary Embolism 9 Thrombosis 5 Multiple Myeloma 4 Pancreatic Neoplasms 2 Neoplasm Metastasis 2 Lymphoma 2 Intracranial Thrombosis 2 Hematologic Neoplasms 2 Carcinoma, Hepatocellular 2 Urinary Bladder Neoplasms 1 Upper Extremity Deep Vein Thrombosis 1 Thromboprophylaxis 1 Thromboembolism 1 Thrombocytopenia 1 Thrombocythemia, Essential 1 Stomach Neoplasms 1 Primary Myelofibrosis 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Polycythemia Vera 1 Neoplasms, Plasma Cell 1 Myeloproliferative Disorders 1 Mesenteric Ischemia 1 Leukemia 1 Head and Neck Neoplasms 1 Glioma 1 Glioblastoma 1 Gastrointestinal Stromal Tumors 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Thromboprophylaxis × apixaban × Clear all

NCT07160686 2025-09-08

THROMBO-STOP

University of Birmingham

Phase 3 Not yet recruiting

Thromboprophylaxis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡